This Week in Otolaryngology — Jun 15, 2026

Welcome to This Week in Otolaryngology. This week we're covering 9 notable papers spanning advances in head and neck oncology, new insights in cochlear implantation and otology, and key management updates in laryngology and head and neck surgery. Let's dive in.

First, in head and neck oncology, three new papers address systems of care, diagnostic technology, and the financial realities of practice. In the journal Head & Neck, a large retrospective study using the National Cancer Database looked at over 100,000 patients with laryngeal squamous cell carcinoma to understand the relationship between hospital volume and survival [1]. Researchers identified a clear inflection point at 10 cases per year. Below this threshold, facility volume had no effect on mortality. However, above 10 cases per year, each doubling of a facility's case volume was associated with an 11% reduction in mortality. The clinical implication is that for early-stage disease, treatment at a facility meeting this 10-case minimum may be sufficient, but for advanced-stage disease, referral to a higher-volume center could be warranted, even if it requires longer travel. Shifting from systems to surveillance, a study in Science Translational Medicine introduces a highly sensitive new tool for postoperative monitoring of HPV-positive head and neck cancer [7]. Current adjuvant therapy decisions rely on clinicopathologic features with limited accuracy. This study prospectively evaluated a novel HPV whole-genome sequencing assay in 103 patients. The results were striking: detection of circulating tumor HPV DNA after surgery was a stronger predictor of recurrence than standard criteria and was associated with significantly worse disease-free and overall survival. This sensitive assay identified molecular recurrence up to 17.5 months earlier than clinical recurrence, suggesting it could become a powerful tool for guiding personalized adjuvant therapy. Finally, in The Laryngoscope, a paper quantifies the economic impact of using a deep learning algorithm for triaging new patient referrals at a high-volume surgical oncology center [4]. The cost-benefit analysis showed that implementing the AI-assisted workflow resulted in a net annual operating gain of over half a million dollars, representing a nearly 15-fold return on investment. This came from two sources: direct labor savings, equivalent to almost one full-time employee, and more critically, the optimization of clinical capacity. The algorithm identified 80 inappropriate referrals in a single year, freeing up those slots for appropriate surgical candidates and generating an estimated 6.2 million dollars in additional downstream revenue.

Turning to otology, we have new data on cochlear implant technology and outcomes, as well as a key diagnostic paper on a rare but serious complication. A multicenter study in The Laryngoscope assessed the safety of a robotic-assisted electrode insertion system for cochlear implantation in 14 children aged 4 to 12 [2]. The procedure was successful in all patients, with no device-related serious adverse events. Surgeons noted that while unique pediatric anatomic features like smaller mastoids require careful planning, they were successfully managed. The authors suggest that robotic assistance holds potential for reducing intracochlear trauma, a critical consideration for pediatric patients who will rely on their device for a lifetime. Providing long-term context for such innovations, a study in Ear and Hearing followed 95 children for eight years to compare cochlear implant outcomes across different etiologies [9]. The findings confirm that children with standard sensorineural hearing loss and those with auditory neuropathy spectrum disorder achieved comparable and successful outcomes. However, children with cochlear nerve deficiency consistently demonstrated lower performance across all measures, and this gap persisted throughout the 8-year follow-up. This underscores that cochlear nerve integrity is a primary determinant of long-term success and highlights the need for tailored habilitation and realistic counseling for families of children with cochlear nerve deficiency. Also in otology, a paper in Otology & Neurotology provides important clues for differentiating otogenic from nonotogenic cerebral venous sinus thrombosis, or CVST [6]. This retrospective analysis of 39 cases found that otogenic CVST, arising from an ear infection, had a distinct clinical signature. It was associated with a 100% incidence of retroauricular erythema, was almost always unilateral and confined to a single sinus, and critically, was associated with significantly lower D-dimer levels. This is a vital distinction, as otogenic CVST requires prompt surgical management of the primary infection, while nonotogenic CVST is managed with anticoagulation. Using D-dimer levels alongside clinical signs and MRV can facilitate this crucial and time-sensitive differentiation.

Finally, we'll cover three papers from The Laryngoscope addressing specific management challenges. First, for patients with idiopathic subglottic stenosis, or iSGS, who become pregnant, a retrospective case-control study provides valuable reassurance [8]. The study evaluated 23 pregnant iSGS patients and found that surgical dilation during pregnancy was safe, with no reported surgical or anesthesia-related complications to mother or baby. While over half of the pregnant patients did require an intervention, the only patient factor associated with needing surgery was being positive for antinuclear antibodies, or ANA. This allows for better counseling and risk stratification for this unique patient population. Next, a practical paper compares two common techniques for managing auricular hematomas after drainage: bolster dressings versus through-and-through quilting sutures [5]. In a 15-year retrospective review of 43 patients, the difference in outcomes was stark. The hematoma recurred in 30% of patients managed with bolsters, but in 0% of those managed with the quilting suture technique. There were no significant differences in other complications or scarring. This provides strong retrospective evidence that quilting may be the superior technique for preventing recurrence. Lastly, a study using the TriNetX United States Research Network database highlights a rare but devastating complication: postoperative pneumothorax after thyroidectomy or parathyroidectomy [3]. Analyzing over 228,000 patients, the study found the incidence to be exceedingly low, at just 0.1%. However, its occurrence was associated with a more than 16-fold increased risk of one-year mortality. It also dramatically increased the risk of pneumonia, dysphagia, vocal cord paralysis, and the need for mechanical ventilation. This paper serves as a potent reminder to maintain a high index of suspicion for this complication and to recognize its grave prognostic significance.

If you only have time for one paper this week, make it the study on HPV whole-genome sequencing for minimal residual disease in Science Translational Medicine [7]. This highly sensitive assay detected molecular recurrence more than a year before clinical recurrence, suggesting it could become a critical tool for guiding adjuvant therapy decisions in HPV-positive head and neck cancer.

Here are the key takeaways from this week in Otolaryngology. First, for laryngeal cancer, facility volume matters, especially for advanced disease. A threshold of at least 10 cases per year appears to be a key inflection point for improved survival [1]. Second, in HPV-positive head and neck cancer, a new highly sensitive circulating tumor DNA assay can detect molecular recurrence over a year before clinical recurrence, potentially revolutionizing postoperative risk stratification and treatment decisions [7]. Third, in pediatric cochlear implantation, long-term outcomes are excellent for both sensorineural hearing loss and auditory neuropathy, but remain significantly poorer for children with cochlear nerve deficiency, highlighting the importance of nerve integrity in counseling [9]. Robotic-assisted insertion appears safe and may help minimize trauma [2]. Fourth, for common auricular hematomas, a retrospective study found that the quilting suture technique was associated with a zero percent recurrence rate, compared to 30 percent for the bolster dressing method [5]. Finally, be aware of two key clinical differentiators: in suspected cerebral venous sinus thrombosis, very low D-dimer levels and unilateral symptoms point towards an otogenic cause requiring surgery, not just anticoagulation [6]; and in pregnant patients with idiopathic subglottic stenosis, ANA positivity is associated with a higher likelihood of needing surgical dilation during pregnancy, though the procedure itself is safe [8].

That's your roundup for This Week in Otolaryngology. The full transcript and references are available on the episode page in your AudioScholar library. This is an AI-curated summary — for clinical decisions, always consult primary sources and current guidelines. See you next week.

If this weekly briefing is useful, follow the show in your podcast app so new episodes arrive automatically. And for audio briefings on your own clinical questions and papers, visit audioscholar dot C C.

This is an automated summary generated by artificial intelligence, which can make mistakes. Always review the original source materials.